Euphorbia lunulata Bunge (ELB) is a traditional Chinese medicine possessing the functions of expectoration, cough relief, asthma relief, detoxification, and itching relief. Modern pharmacological studies have showed that ELB exhibits a variety of activities, such as antitumor, antibacterial, and antioxidant activities. In particular, the anticancer activities of ELB have attracted much attention. In this review, we summarize the recent research progress on the chemical constituents and anticancer activities of ELB by searching the PubMed, Web of Science, and China National Knowledge Infrastructure databases. e results show that more than 151 components have been identified from extracts of ELB, including 73 terpenoids, 28 flavonoids, 8 phenylpropanoids, 7 steroids, 19 phenols, and 5 alkaloids. ELB has been shown to exhibit significant inhibitory effects on lung, cervical, gastric, breast, and liver cancers, and its anticancer effects are mainly manifested in the 3 aspects, including cell cycle arrest, cell apoptosis, and inhibition of the migration of cancer cells.
Introduction
Cancer, one of the most common malignancy tumors, is a group of diseases characterized by irregular unlimited growth and proliferation of abnormal cells, as well as imbalance of apoptosis [1] . In 2012, the WHO's GLOBOCAN estimated approximately 14.1 million new cancer cases and 8.2 million deaths worldwide, which are expected to rise to 22 million in the next two decades [2] . Current methods for treating cancers, such as chemotherapy, radiotherapy, molecular targeted therapy, and immunotherapy, are not always satisfactory. Among them, molecular targeted therapy and radiotherapy have significant side effects on patients, especially elderly patients. Furthermore, chemotherapy drugs typically have a single selectivity and low tolerance [3] [4] [5] . erefore, finding and developing more effective and safer methods for treating cancers have become an important research direction for researchers.
Research into the sources of new drugs indicates that natural products play an important role in drug discovery and development for the treatment of some human diseases, including for tumors. According to incomplete statistics, anticancer agents derived from botanical drugs accounted for 32.25% of total anticancer drugs [6, 7] . In addition, some ingredients extracted from natural products (e.g., camptothecin, taxol, vinblastine, and vincristine) have become the first choice for treating some tumors [8] [9] [10] [11] . China is abundant in traditional Chinese medicine (TCM) resources. Chinese herbal medicines have the advantages of rich active ingredients, diverse structures, limited side effects, and a wide anticancer spectrum; therefore, the extraction of new antitumor active compounds from TCM has become a widely popular topic in recent years [12] [13] [14] [15] [16] [17] [18] .
Euphorbia lunulata Bunge (ELB), recorded as Euphorbia esula L. in Chinese flora [19] , is a traditional Chinese medicine, mainly distributed in the northeastern and northern regions of China, which is widely distributed in Eurasia and naturalized in North America and worldwide [19] . ELB possessed the functions of expectoration, cough relief, asthma relief, detoxification, and itching relief and has been widely used in the treatment of phlegm, coughs, asthma, edema, scabies, and anonymous swelling [20] , as well as for lung cancer, gastric cancer, lymph node nucleus [21] , rheumatic immune diseases [22] , and psoriasis [23] . Modern pharmacological studies have shown that ELB exhibits a variety of activities, such as antitumor, antibacterial [24] , and antioxidant [25] activities. Studies have shown that ELB has significant anticancer activity, whether used alone [26] or in combination with other drugs [27] .
In recent years, scholars, both at home and abroad, have showed great interest in ELB because of its anticancer efficacy. us, many of the chemical constituents of ELB have been isolated, such as terpenoids, flavonoids, steroids, phenylpropanoids, phenols, and other chemical constituents ; yet, few of these ingredients have been tested for their anticancer activities. Until recently, not much attention has been paid to the screening of its active anticancer components. erefore, a comprehensive and systemic review of the chemical constituents of ELB and their associated anticancer activities is indispensable for its further research and clinical applications.
Constituents
More than 151 compounds have been isolated and identified from ELB so far, including diterpenoids, triterpenes, flavonoids, steroids, alkaloids, coumarins, lignins, phenols, and volatile oils.
Terpenoids.
e terpenoids have been given more attention since the discovery of taxol, and the terpenoids are the most abundant components in ELB. Up to now, 73 terpenoids have been isolated and identified from ELB, which contained 56 diterpenoids and 17 triterpenoids.
Diterpenoids.
Euphorbia is rich in diterpenoids. So far, there have been more than 56 kinds of diterpenoids isolated from ELB, which can be classified into four classes: ingenane-type, jatrophane-type, abietane-type, and other types of diterpenes.
Among them, 20 kinds of ingenane-type diterpenoids (see Figure 1 ) have been isolated from ELB, including 17-ben- [28] , 17-benzoyloxy-13-octanoyloxyingenol (5) [28] , 3-O-benzoyl-17-benzoyloxy-13-octanoyloxyingenol (6) [28] , 20-O-benzoyl-17-benzoyloxy-13-octanoyloxyingenol (7) [28] , 3-O-benzoyl-17-benzoyloxy-13-octanoyloxy-20-deoxyingenol (8) [28] , 17-benzoyloxy-3-O-(2,3-dimethylbutanoyl)-13-octanoyloxyingenol (9) [28] , 17-benzoyloxy-20-O-(2,3-dimethylbutanoyl)-13-octanoyloxyingenol (10) [28] , 3-O-benzoyl-13,17-dibenzoyloxyingenol (11) [28] , 13,17-dibenzoyloxy-3-O-(2,3-dimethylbutanoyl)ingenol (12) [28] , 3-O-benzoyl-17-benzoyloxy-13-(2,3-dimethylbutanoyloxy)ingenol (13) [28] , 13,17-dibenzoyloxy-3-O-(2,3-dimethylbutanoyl)-20-deoxyingenol (14) [28] , 3-O-benzoyl-13-octanoyloxyingenol (15) [28] , 3-O-(2,3-dimethylbutanoyl)-13-octanoyloxyingenol (16) [28] , 6-benzoyloxy-20-deoxyingenol-5-benzoate (17) [29] , ingenol-3,20dibenzoate (18) [30] , 13,16-dibenzoyloxy-20-deoxyingeno-3-benzoate (19) [31] , and kansuiphorin D (20) [32] .
As shown in Figure 2 , 28 kinds of jatrophane-type diterpenoids have been isolated from ELB, such as 2α,3β,5α,9α,15β-pentaacetoxy-11,12-epoxy-7β-isobutyryl-8αbenzoyloxyjatropha-6(17)-en-14-one (21) [33] , salicinolide (22) [34] , 2α,3β,5α,9α,15β-pentaacetoxy-11,12-epoxy-7β,8αdiisobutyryloxyjatropha-6(17)-en-14-one (23) [34] , 3β,5α,15β-triacetoxy-7β-isobutyryloxy-9α-nicotinoyloxyjatropha-6(17),11(E)-dien-14-one (24) [34] , euphoscopin M (25) [32] , alisol A (26) [32] , euphornin A (27) [32] , 14α,15βdiacetoxy-3α,7β-dibenzoyloxy-9-oxo-2βH,13-αHjatropha-5E,11E-diene (28) [35] , euphornin (29) [35] , euphoscopin B (30) [35] , euphornin N (31) [35] , esulatinsH(2R,3β,5R, 8R,9R,12R,15β-heptaacetoxy-11,14-epoxy-14R-hydroxy-7βisobutanoyloxyjatropha-6(17)-ene) (32) [36] , esula-tinsI(3,5,7,15-tetraacetoxy-2-benzoyloxyjatropha-6(17),11-diene-9,14-dione) (33) [36] , esulatinsJ(3β,5R,15β-triacetoxy-7βisobutanoyloxyjatropha-6(17),11Ediene-9,14-dione) (34) [36] , esulatinsK (35) [36] , esulatinsL(2R,3β,5R,15β-tetraacetoxy-7β-isobutanoyloxy-9R-nicotinoyloxyjatropha-6(17),11E-dien-14-one) (36) [36] , esulatinsM(3β,5R,15β-triacetoxy-7β-isobutanoyloxy-9R-nicotinoyloxyjatropha-6(17),11-dien-14-one) (37) [36] , 2R,3β,5R,7β,15β-pentaacetoxy-9R-nicotinoyloxyjatropha-6(17),11-dien-14-one (38) [36] , salicinolide (39) [36] , euphosalicin (40) [36] , esulatinsA(2R,3R,4S,5R,7S,8R, 9S,11R,12S,13R,15R)-2,3,5,8,9,15hexaacetoxy-11,12-epoxy-7-(isobutanoyloxy)jatroph-6(17)en-14-one (41) [37] , esu-latinsB(2,3,5,7,15-pentaacetoxyjatropha-6(17),11-diene-9,14dione) (42) [37] , esulatinsC (43) [37] , esulatinsD (44) [38] , esulatins (2,3,5,15-tetraacetoxyjatropha-6(17),7E,11E-triene-9,14-dione) (45) [38] , 11,14-epoxy-3β,5α,7β,8α,9α,15β-hexaacetoxy-12-oxo-13αH-jatropha-6(17)-ene (46) [39] , 1α,3βdiacetoxy-5α,7β-dibenzoyloxy-9,14-dioxo-11β,12α-expoxy-2α,8α,15β-trihydroxy-13αH-jatropha-6(17)-ene (47) [39] , and esulol A (48) [40] . 5 kinds of abietane-type diterpenoids, including 17hxdroxyjolkinolide A (49) [41] , jolkinolide A (50) [41] , jolkinolide B (51) [41] , 18-hydroxyhelioscopinolide A (52) [32] , and Ent-3α-formylabieta-8(14),13(15)-dien-16,12βolide (53) [35] , have been isolated from ELB; in addition, 3 other types of diterpenes including esulatinG (54) [42] , 5,8,14-triacetoxy-3-benzoyloxy-15-hydroxy-9-oxo-paraliane (55) [42] , and cassipourol (56) [34] have been isolated; the structures of these 8 compounds are shown in Figure 3 .
Triterpenes.
So far, 17 triterpenoids were isolated from the ELB, which could be classified into tetracyclic triterpenes and pentacyclic triterpenes. Among them, except for euphor (57) [34] , the other 10 tetracyclic triterpenes ( Figure 4 ) were all cycloartane-type triterpenes, including 24-methylenecycloartan-3β-ol (58) [43] , 25-hydroperoxycycloart-23en-3β-ol (59) [34] , 25-hydroperoxycycloart-23-en-3β-ol (60) [34] , (23E)-25-methoxycycloart-23-en-3β-ol (61) [34] , (23E)-cycloart-23,25-dien-3β-ol (62) [34] , 24-methylenecycloartan-3β,28-diol (63) [34] , 3-hydroxylcycloartane-25-ene (64) [34] , 25,26,27-trinor-3αhydroxycycloartan-24-oic acid (65) [35] , cycloart-23ene-3β,25-diol (66) [35] , and cycloart-23-ene-3β,25,28triol (67) [35] . And 6 pentacyclic triterpenes including three oleanane-type triterpenoids (68-70), one ursanetype triterpenoid (71), and two lupane-type triterpenoids (72,73), respectively, named β-amyrin (68) [43] , corosolic acid (69) [45] , ursolic acid (70) [35] , uvaol (71) [34] , lupeol (72) [34] , and betulin (73) [34] , have been isolated and identi ed. And the structure of 6 pentacyclic triterpenes is presented in Figure 5 .
Flavonoids.
Until now, more than 28 avonoids have been isolated from ELB, which could be structurally divided into dihydro avones, iso avones, and avonoids. Among them, 26 avonoids (74-99), such as 3,5,7-trihydroxy-8methoxy avone (74) [43] , naringenin-7-O-β-D-glucoside (75) [22] , quercetin-3-O-(6″-galloyl)-β-D-galactopyranoside (76) [22] , apigenin-7-O-β-D-glucoside (77) [22] , kaempferol-7-O-β-D-glucoside (78) [44] , quercetin-7-Oβ-D-glucoside (79) [44] , quercetin-3-O-α-L-rha (80) [44] , kaempferol-3-O-(6″-galloyl)-β-D-glucoside (81) [44] , kaempferol-3-O-β-D-glucoside (82) [44] , jaceosidin (83) [45] , myricetin-3-O-(2″,3″-digalloyl)-β-D-galactopyranoside (84) [46] , myricetin-3-O-(2″-galloyl)-β-D-galactopyranoside (85) [46] , myricitrin (86) [46] , myricetin (87) [46] , apigenin (88) [46] , luteolin (89) [46] , 3-O-methylquercetin (90) [46] , 5,7,2′,5′-tetrahydroxy avone (91) [46] , kaempferol (92) [47] , quercetin (93) [47] , quercetin-3-L-rha (94) [47] , kaempferol-3-L-rha (95) [47] [48] , hyperin (98) [48] , and quercetin-3-0-β-glucuronic (99) [49] , have been isolated and identi ed from ELB. In addition, a dihydroavone and an iso avone, named 5,7,4′-trihydroxydihydro avone (100) [45] and isoquercetin (101) [46] , was isolated and identi ed. e structures of these 28 avonoids are presented in Table 1 and Figure 6 .
2.3. Phenylpropanoid. 8 phenylpropanoids (102-109) were isolated from ELB, which could be divided into two classes: coumarins and lignans. 5 coumarins have been isolated, including scopolin (102) [41] , scopoletin (103) [22] , isofraxidin (104) [22] , esculetin (105) [47] , and maoyancaosu (106) [47, 50] . 3 lignans were isolated and identi ed from ELB, respectively, named [51] , and isoanmericanon A (109) [51] . e structures of 8 phenylpropanoids are listed in Figure 7 . Figure 8 , 7 steroids have been isolated from ELB, including β-sitosterol (110) [44] , stigmasterol (111) [44] , 3β-hydroxy-7β-methoxy-5-stigmasterone (112) [45] , 3β, 22β-dihydroxy-7β-methoxy-5-stigmasterone (113) [45] , β-daucosterol (114) [32] , stigmast-4-ene-3β,6βdiol (115) [35] , and stigmastane-3,6-dione (116) [35] . [46] , 3,3′-di-O-methylellagic acid (120) [46] , ellagic acid (121) [46] , gallic acid (122) [46] , protocatechuic acid (123) [46] , 3,4,5-trimethoxybenzoic acid (124) [46] , 2,6-dihydroxyacetophenone (125) [46] , ethyl gallate (126) [51] , octadecyl ca eate (127) [41] , hexadecyl ferulate (128) [41] , p-hydroxybenzoic acid (129) [45] , 3hydroxy-4-methoxybenzoic acid (130) [45] , 2,5-dihydroxy-4-methoxy phenanthrene (131) [45] , erigeside C (132) [45] , 4,8-dihydroxy-1-tetralone (133) [52] , methyl 3,4-dihydroxybenzoate (134) [52] , and vifolin (135) [43] . eir structures are listed in Figure 9 . [52], N-[2-(1H-indol-3-yl)ethyl]acetamide (138) [52] , N-[2-(4-hydroxyphenyl)ethyl]acetamide (139) [52] , and 2,3dihydroxy-methyl nitrogen (140) [52] . eir structures are presented in Figure 10 .
Steroids. As shown in

Phenols. 19 phenols (117-135) have been obtained from
ELB, including 1,3,4,6-tetra-O-galloyl-β-D-glucose (117) [46], 1,2,6-tri-O-galloyl-β-D-glucose (118) [46], 1,3,6-tri-O- galloyl-β-D-glucose (119)
Long-Chain Aliphatic Group. 4 compounds, which
belonged to the long-chain aliphatic group, were isolated, including n-octadecyl alcohol (141) [41] , cetyl alcohol (142) [44] , triacontanol (143) [44] , and tetracatanol (144) [44] .
Volatile Oils.
Wang et al. [53] used steam distillation to extract volatile oil from ELB and analyze the chemical constituents of volatile oil by gas chromatography-mass spectrometry (GC-MS). 43 components were identi ed, and the relative percentage of each component was calculated by the peak area normalization method. e identi ed components accounted for 75.86% of the total out ow peak area. Among them, 3 main compounds including 3,4,4-trimethyl-2-cyclopenten-1-one (12.67%) (145), phenylacetaldehyde (12.36%) (146), α-terpineol (4.47%) (147) and 2 active ingredients including eucalyptol (148) and borneol (149) were identi ed. eir structures are shown in Figure 11 .
Others.
Other chemical constituents other than terpenoids, phenylpropanoids, avonoids, steroids, phenols, alkaloids, long-chain aliphatic group, volatile oils, such as ophthalic acid bis-(2-ethyl decyl)-ester (150) [41] , and sucrose (151) [41] , were isolated, the structures of which are shown in Figure 12 
Antitumor Pharmacological Activity
At present, the mechanism of the occurrence and development of cancer has not been fully revealed; however, it has been con rmed that the proliferation of cancer cells originates from their ability to avoid programmed cell death (i.e., the so-called apoptosis). erefore, inducing cancer cell apoptosis has been identi ed as a target for cancer treatment [54] [55] [56] [57] . ELB has exhibited antitumor activity, having signi cant inhibitory e ects on lung, cervical, gastric, breast, and liver cancers. Its anticancer e ects are mainly manifested in the following aspects: (1) inhibiting the growth of cancer cells by regulating cell cycles, (2) [59, 60] reported that an aqueous extract of ELB exhibited signi cant inhibitory activities against the growth of Lewis lung cancer in a mouse model: a ow cytometry assay showed that the S phase percentage of the cell cycle was increased at doses of 30 g·kg − 1 and 60 g·kg − 1 with apoptotic rates of (16.43 ± 18.69)% and (24.37 ± 15.48)%, respectively. e apoptotic index (AI) of the 60 g·kg − 1 group was signi cantly higher than the control group, with a value of (5.93 ± 5.96)%. 6 BioMed Research International erefore, ELB could induce apoptosis at a dose of 60 g·kg − 1 . Jiang [61] found that a avonoid extract of ELB could inhibit the growth of Lewis lung cancer mice and that rabbit serum containing ELB could signi cantly inhibit the proliferation of A549 lung cancer cells in a concentration-and timedependent manner: at a concentration of 20% for 72 h, the A549 proliferation inhibiting rate was 39.08%; thus, rabbit serum containing ELB extract could induce signi cant A549 cell apoptosis by arresting the cell in the G1 phase. Western blotting analysis showed that the active ingredients of ELB could inhibit the phosphorylation of EGFR and downregulate AKT and ERK signals. However, Wang et al. [62] found that extracts of ELB could induce the apoptosis of A549 cells, which may be related to an increase in bax expression and a decrease of bcl-2 expression. Liu et al. [35] evaluated in vitro antiproliferative activities against NCI-H460 human lung carcinoma cell lines of ve compounds (compounds 28-31 and 53) , where the results showed that compound 53 exhibited marked activity, with an IC50 value of 19.5 μM, and compounds 28-31 showed moderate cytotoxic activities, with IC50 values of 58.2 (compound 28), 53.1 (compound 29), 33 .0 (compound 30), and 36.7 (compound 31) μM.
Cervical Cancer.
Cervical cancer is the second most common cancer, a ecting women's health worldwide [63] . Ming et al. [64] discovered that an ELB extract could eciently inhibit HeLa cervical cancer cell proliferation and induce the apoptosis of HeLa cells by downregulating the expression levels of Cyclin D1, Cyclin E, and CDK4 proteins and upregulating the expression levels of the P21 protein. Tu et al. [65] reported that an ELB extract could inhibit SiHa human cervical cancer cell proliferation and induce cell apoptosis by increasing the expression levels of caspase-3 and caspase-9.
Gastric Cancer.
Cancer multidrug resistance is the term used to describe a phenomenon in which once a cancer develops resistance to one chemotherapeutic drug, it will become resistant to many (or all) other chemotherapeutic drugs (which may or may not have the same mechanism of action). Cancer multidrug resistance has become a problem that cannot be ignored in clinical practice, and many studies are being carried out to nd ways to combat or reverse it [66] [67] [68] [69] [70] . Fu et al. reported that the proliferation, migration, and invasion of multidrug-resistant human gastric cancer cell line SGC7901/ADR were signi cantly inhibited by an nhexane extract of ELB in a time-and dose-dependent manner: the cell cycle was arrested in the G2/M phase, and cell apoptosis was induced.
e result of the related mechanisms showed that the extract could upregulate the expression of the apoptosis-promoting protein Bax and downregulate that of the apoptosis-inhibiting protein Bcl-2, as well as increasing the activities of caspase-3, caspase-8, and caspase-9 [71, 72] . In addition, the ELB extract could increase the sensitivity of the multidrug-resistant human gastric cancer cell SGC7901/ADR to the chemotherapy drugs paclitaxel and adriamycin, which was manifested in two aspects: it increased the growth inhibitory e ects of paclitaxel and adriamycin to SGC7901/ADR gastric cancer cells and signi cantly reduced the IC50s of paclitaxel and adriamycin to SGC7901/ADR cells, in a concentration-dependent manner [73] . 
Liver and Breast
Discussion and Conclusion
ELB is a traditional Chinese medicine possessing the functions of expectoration, cough relief, asthma relief, detoxi cation, and itching relief. Modern pharmacological studies have shown that ELB exhibits a variety of activities, such as antitumor, antibacterial, and antioxidant. In particular, its anticancer activities have been paid much attention in recent years. e present review summarizes the chemical constituents and the antitumor activities. e results showed that more than 151 components have been identi ed from extracts of ELB, including 73 terpenoids, 28 avonoids, 8 phenylpropanoids, 7 steroids, 19 phenols, and 5 alkaloids. ELB has been shown to exhibit signi cant inhibitory e ects on lung, cervical, gastric, breast, and liver cancers. However, there are limitations associated with most of these studies: (1) most of the studies reported to date have focused exclusively on the use of ELB fractions, as well as the use of its crude extracts; in contrast, there have been very few reports pertaining to the use of single compounds isolated from ELB; (2) most of the studies concerning the anticancer activities and mechanisms have been conducted using in vitro cellular systems, which could explain how nonspeci c cell cycle arrest and apoptosis were induced. However, very few reports have focused on speci c molecular targets or enzymatic pathways; and (3) to our knowledge, there exist no studies concerned with the anticancer mechanisms of single compounds isolated from ELB. erefore, systematic research should be carried out to isolate the monomer components and screen the anticancer activity of these components, in order to con rm the anticancer active ingredients and further study on the anticancer activities and mechanisms of these ingredients, which will be useful in discovering new active anticancer single compounds and new anticancer drug resources.
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